16 unchanged sentences
OTHER INFORMATION
−Removed: Not applicable.
+Added: Rule 10b5-1 Trading Arrangements
+Added: The following table describes the written plans for the sale of our Class A ordinary shares adopted or terminated by our executive officers and directors during the fourth quarter of 2023, each of which is intended to satisfy the affirmative defense conditions of Rule 10b5-1 (each, a “Trading Plan”).
+Added: Name and Title Action Adoption/ Termination Date
+Added: Scheduled Expiration Date of Trading Plan (1)
+Added: Maximum Shares Subject to Trading Plan
+Added: Terrance Coyne
+Added: Executive Vice President & Chief Financial Officer
+Added: November 22, 2023 October 17, 2024 480,000
+Added: Marshall Urist
+Added: Executive Vice President, Research and Investments
+Added: December 20, 2023 December 30, 2024 46,667
+Added: (1) A Trading Plan may expire on an earlier date if all contemplated transactions are completed before such Trading Plan’s expiration date, upon termination by broker or the holder of the Trading Plan, or as otherwise provided in the Trading Plan.
DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS
24 unchanged sentences
Incorporated by Reference
−Removed: Exhibit Number
−Removed: Exhibit Description
−Removed: Form Exhibit Filing Date/
+Added: Exhibit Number Exhibit Description Form Exhibit Filing Date/
Period End Date Filed or Furnished Herewith
36 unchanged sentences
S-1 10.13 5/22/2020
−Removed: 10.13 Amended and Restated Management and Services Agreement dated October 3 , 202 2 , among Royalty Pharma Holdings L td and RP Management, LLC
+Added: 10.13 Amended and Restated Management and Services Agreement dated October 3, 2022, among Royalty Pharma Holdings Ltd and RP Management, LLC
10-Q 10.2 11/08/2022
15 unchanged sentences
8-K 4.2 7/26/2021
+Added: 10.21 Amended and Restated Revolving Credit Agreement, dated as of September 15, 2021, as amended by Amendment No.
+Added: 1, dated as of October 31, 2022, as amended by Amendment No.
+Added: 2, dated as of May 16, 2023, as amended by Amendment No.
+Added: 3, dated as of December 22, 2023, as amended by Amendment No.
+Added: 4, dated as of January 24, 2024, among Royalty Pharma plc, Royalty Pharma Holdings Ltd., Bank of America, N.A., as Administrative Agent, the other parties thereto, and the lenders and issuing banks from time to time party thereto
21.1 Subsidiaries of the Registrant
5 unchanged sentences
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
−Removed: XBRL Taxonomy Extension Instance Document
−Removed: XBRL Taxonomy Extension Schema Document
−Removed: XBRL Taxonomy Extension Calculation Linkbase Document
−Removed: XBRL Taxonomy Extension Definition Linkbase Document
−Removed: XBRL Taxonomy Extension Label Linkbase Document
−Removed: XBRL Taxonomy Extension Presentation Linkbase
+Added: 97.1 Financial Restatement Compensation Recoupment Policy
+Added: 101.INS XBRL Taxonomy Extension Instance Document
+Added: 101.SCH XBRL Taxonomy Extension Schema Document
+Added: 101.CAL XBRL Taxonomy Extension Calculation Linkbase Document
+Added: 101.DEF XBRL Taxonomy Extension Definition Linkbase Document
+Added: 101.LAB XBRL Taxonomy Extension Label Linkbase Document
+Added: 101.PRE XBRL Taxonomy Extension Presentation Linkbase
104 Cover Page Interactive Data File (formatted in iXBRL and contained in Exhibit 101) x
40 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.